✦ LIBER ✦

Ifosfamide with mesna in squamous carcinoma of the cervix: Phase II results in patients with advanced or recurrent disease

✍ Scribed by E.V. Hannigan; T.V. Dinh; M.G. Doherty

Book ID: 119053786
Publisher: Elsevier Science
Year: 1991
Tongue: English
Weight: 576 KB
Volume: 43
Category: Article
ISSN: 0090-8258
DOI: 10.1016/0090-8258(91)90057-c

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II trial of ifosfamide and mesna i

Phase II trial of ifosfamide and mesna in chemotherapy-naive patients with recurrent or advanced squamous carcinoma of the cervix

✍ G. Sutton; J. Blessing; W. McGuire; T. Patton 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 159 KB

Phase II trial of vinblastine in patient

Phase II trial of vinblastine in patients with advanced or recurrent squamous carcinoma of the cervix

✍ G. Sutton; J. Blessing; D. Smith; W. Barnes 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 325 KB

Phase II trial of ifosfamide and mesna i

Phase II trial of ifosfamide and mesna in patients with advanced or recurrent squamous carcinoma of the cervix who had never received chemotherapy: A Gynecologic Oncology Group study

✍ Sutton, Gregory P.; Blessing, John A.; McGuire, William P.; Patton, Thomas; Look 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 338 KB

Phase II study of ifosfamide and mesna i

Phase II study of ifosfamide and mesna in patients with previously-treated carcinoma of the cervix

✍ Gregory P. Sutton; John A. Blessing; Leon Adcock; Kenneth D. Webster; Timothy De 📂 Article 📅 1989 🏛 Springer US 🌐 English ⚖ 223 KB

Phase II trial of ifosfamide and cis-pla

Phase II trial of ifosfamide and cis-platinum in advanced or recurrent squamous carcinoma of the cervix: Preliminary report

✍ M. Rodriguez; K. Look; M. Callagan; G. Sutton 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 161 KB

Phase II study of ifosfamide with mesna

Phase II study of ifosfamide with mesna in adult patients with recurrent diffuse astrocytoma

✍ T. E. Elliott; J. C. Buckner; T. L. Cascino; R. Levitt; J. R. O'Fallon; B. W. Sc 📂 Article 📅 1991 🏛 Springer US 🌐 English ⚖ 318 KB

Sixteen patients who developed CT or MRI scan evidence of recurrent diffuse astrocytoma after radiation therapy and nitrosourea-containing chemotherapy received ifosfamide (2500 mg/m2/day for 3 consecutive days) and mesna (500mg/m2/dose, 5 doses/day for 3 consecutive days). Toxicity consisted primar